Bayer to Shed Assets, Cut Jobs Amid Share Pressure
It's a broad restructuring of the German conglomerate, which plans to sell its sun-care and foot care businesses and exit its animal health division.
Monsanto Cancer Verdict Rattles Bayer Shares
Analysts warn Bayer could face a "litigious headache" after the $289 million jury award in a product liability case over Monsanto's Roundup pesticide.
Monsanto Misses Estimates on Corn Slowdown
"Despite tough farm economics, we delivered a solid second quarter and are staying disciplined on near-term execution of the business," CEO Hugh Grant says.
BASF to Buy Bayer Seed Businesses for $6.9B
The deal may help clear the way for European authorities to approve Bayer's acquisition of Monsanto early next year.
Free from Bayer, Covestro Finally Can Build for the Future
The spun-off materials science company had to build out most functions from scratch but has seen surprising early business results.
Bayer Clinches Monsanto Takeover for $66B
The deal continues the wave of consolidation in agribusiness, pairing Bayer's strength in crop chemicals with Monsanto's portfolio of seed products.
The Year of Dealing Dangerously
Antitrust actions, buyer cautiousness, and longer due diligence phases have all contributed to a slowdown in mergers and acquisitions.
Bayer Discloses $62B Offer for Monsanto
The deal would create the world's largest agricultural supplier but Bayer shareholders fear it will be detrimental to its pharmaceutical business